TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
PYPD

PolyPid

Healthcare · Biotechnology

5.30$ -0.4% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow PYPD
Line item 2013 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– +52.1% +17.6% +61.4% +100.5% +130.4% +6.9% +10.5% +53.9% +5.9% -11.0% -10.1%
– – – +129.9% -27.6% -1.9% +369.0% +3.8% -9.3% -21.3% -16.7% +71.9%
– – – +2,283.2% -155.7% – – -70.2% -3.2% – – –
– +279.2% -109.8% – – -314.2% – – -124.8% – – -81.3%
– +135.4% +377.0% +249.5% +63.2% -71.4% +33.8% +154.5% -41.0% -88.9% -61.2% +176.3%
– +112.5% +7,810.8% +3.9% – -315.1% +73.0% – -55.1% -77.0% -108.7% –
– +47.7% +589.5% -45.4% -34.7% +301.1% – – – – – –
– – – – – – +0.0% +0.0% +0.0% -123.1% +26.9% +91.9%
– +112.1% +325.7% -45.4% -34.7% +301.1% +66.7% -98.4% +1,488.8% -39.3% +224.9% -21.7%
– +0.0% +2,333.6% -173.9% – -189.2% – +1,243.2% -120.9% – – -190.3%
– – – – – – – – – – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?